Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation

NCT06960031 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06960031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06960031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation
Lead sponsor
Tanta University
Phase
Observational
Overall status
Completed
Start date
December 30, 2024
Completion date
April 30, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular malignancy, pet/ct, radiofrequency ablation